C V Technologies Inc.
Records under this name other than patents C V Technologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,593,340 | Pharmaceutical Compositions Containing N-Propargylphentermine and Related Analogs to Treat Neurodegeneration And/Or Depression Formerly held Term ended Term ended Feb 28, 2021 · High confidence | Term ended | Term ended Feb 28, 2021 | High confidence |
| US 6,432,454 | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators Formerly held Term ended Term ended Jul 27, 2020 · From the USPTO record | Term ended | Term ended Jul 27, 2020 | From the USPTO record |
| US 7,186,423 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Uses as Immunomodulators Formerly held Term ended Ended no later than Feb 6, 2020 · Low confidence | Term ended | Ended no later than Feb 6, 2020 | Low confidence |
| US 7,413,756 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Use as Immunomodulators Formerly held Term ended Term ended Dec 13, 2019 · Medium confidence | Term ended | Term ended Dec 13, 2019 | Medium confidence |
| US 7,195,783 | Hypericin and hypericum extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics Formerly held Term ended Term ended Jul 9, 2019 · From the USPTO record | Term ended | Term ended Jul 9, 2019 | From the USPTO record |
| US 7,067,160 | Processes of Making North American Ginseng Fractions, Products Containing Them, and Use as Immunomodulators Formerly held Term ended Term ended Jun 28, 2019 · Medium confidence | Term ended | Term ended Jun 28, 2019 | Medium confidence |
| US 7,358,342 | Preparation Derived from Shark Cartilage for Treatment of Diseased Related to Excessive PHF or Excessive Intracellular Calcium Formerly held Term ended Term ended Oct 13, 2018 · Medium confidence | Term ended | Term ended Oct 13, 2018 | Medium confidence |
| US 6,156,291 | Chemical and pharmacological standardization of herbal extracts Formerly held Term ended Term ended Aug 28, 2018 · From the USPTO record | Term ended | Term ended Aug 28, 2018 | From the USPTO record |
| US 6,083,932 | Pharmaceutical compositions derived from ginseng and methods of treatment using same Formerly held Term ended Term ended Apr 17, 2018 · From the USPTO record | Term ended | Term ended Apr 17, 2018 | From the USPTO record |
| US 6,060,516 | N.sup.1 -propargylhydrazines, N.sup.2 -propargylhydrazines and their analogs for the treatment of depression, anxiety and neurodegeneration Formerly held Term ended Term ended Feb 17, 2018 · From the USPTO record | Term ended | Term ended Feb 17, 2018 | From the USPTO record |